Shire Says Genzyme Can't Prove False Bone Drug Claims
A Shire PLC unit asked a Massachusetts federal court on Tuesday to dismiss Genzyme Corp.'s complaint alleging Shire misled consumers by advertising its bone disease drug as superior to Genzyme's Cerezyme,...To view the full article, register now.
Already a subscriber? Click here to view full article